跳至主要内容
临床试验/NCT00660114
NCT00660114已完成不适用

A Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Patient Aged 5-Year Old or Younger in Outpatient Department

AstraZeneca1 个研究点 分布在 1 个国家目标入组 914 人开始时间: 2008年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
914
试验地点
1
主要终点
Patient Symptom Score

研究概览

简要总结

This open label, non-interventional study is to show the efficacy of Pulmicort®Respules® in cough variant asthma in patient aged 5-year old or younger in outpatient department

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
— 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Provision of informed consent
  • Patient who has been prescribed Pulmicort® Respules® according to physician's judgement, irrespective of the inclusion in the study.
  • The usage of Pulmicort® Respules® follows local authorised package insert.

排除标准

  • Allergy to any ingredient of Pulmicort® Respules®
  • With history of Leukotriene Modifier (LM) usage prior to 2 weeks of recruitment or following plan.
  • Have used systemic/inhaled steroid prior to 2 weeks of recruitment

结局指标

主要结局

Patient Symptom Score

时间窗: 7 weeks (plus or minus 3 days )

次要结局

  • Patient Compliance Report(7 weeks (plus or minus 3 days ))
  • Investigator Assessment Report(7 weeks (plus or minus 3 days ))

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验